Shares outstanding

Investor Group Led by Entrepreneur and Collector Nat Turner Successfully Completes Tender Offer for Shares of Collectors Universe

Retrieved on: 
Monday, February 8, 2021
Corporate finance, Finance, Financial economics, Money, Stock market, Equity securities, Stock, Shares outstanding

All of such shares have been accepted for payment in accordance with the terms of the tender offer, and the Investor Group will promptly pay for such shares, other than the rollover shares.

Key Points: 
  • All of such shares have been accepted for payment in accordance with the terms of the tender offer, and the Investor Group will promptly pay for such shares, other than the rollover shares.
  • When taken together, the shares tendered and delivered pursuant to guaranteed delivery procedures represent approximately 69% of the outstanding shares of the Companys common stock.
  • The Investor Group intends to complete its acquisition of Collectors Universe today through the merger of Cards Acquisition Inc., an entity controlled by the Investor Group, with and into Collectors Universe.
  • This information is accessible to collectors and dealers at the Company's website, http://www.collectorsuniverse.com, and is also published in print.

MDxHealth Shareholder Transparency Declarations

Retrieved on: 
Wednesday, February 3, 2021
Corporate finance, Fundamental analysis, Shares outstanding

Soleus Capital Management, L.P. notified MDxHealth that the number of shares with respect to which Soleus Capital Management, L.P. can exercise voting rights actively crossed above the threshold of 5% of the outstanding shares and voting rights of MDxHealth on 26 January 2021.

Key Points: 
  • Soleus Capital Management, L.P. notified MDxHealth that the number of shares with respect to which Soleus Capital Management, L.P. can exercise voting rights actively crossed above the threshold of 5% of the outstanding shares and voting rights of MDxHealth on 26 January 2021.
  • Notably, it follows from the notification by Soleus Capital Management, L.P. that 6,300,000 shares of MDxHealth, representing 5.32% of the 118,469,226 outstanding shares and voting rights of MDxHealth, are held through Soleus Capital Master Fund, L.P.
  • Biovest NV notified MDxHealth that the number of shares with respect to which Biovest NV can exercise voting rights passively crossed below the threshold of 10% of the outstanding shares and voting rights of MDxHealth on 26 January 2021.
  • Notably, it follows from the notification by Biovest NV that 11,090,257 shares of MDxHealth, representing 9.36% of the 118,469,226 outstanding shares and voting rights of MDxHealth, are held through Biovest NV.

MDxHealth's New Share Capital Amount and New Number of Shares

Retrieved on: 
Tuesday, January 26, 2021
Corporate finance, Fundamental analysis, Shares outstanding, Irvine, California, Medical diagnosis, Academic disciplines

In addition to the outstanding shares, the total number of outstanding subscription rights on the moment of this press release amounts to 6,188,593, which entitles their holders (if exercised) to subscribe to 6,188,593 new shares with voting rights in total.

Key Points: 
  • In addition to the outstanding shares, the total number of outstanding subscription rights on the moment of this press release amounts to 6,188,593, which entitles their holders (if exercised) to subscribe to 6,188,593 new shares with voting rights in total.
  • MDxHealth is a commercial-stage, innovative healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer.
  • The Companys European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.
  • For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth , facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

Mkango Receives TSX Venture Exchange Approval for Talaxis Cashless Warrant Exercise

Retrieved on: 
Thursday, January 7, 2021
Corporate finance, Financial markets, Financial economics, Finance, Stock market, Equity securities, Corporate law, Options, Stock dilution, Issued shares, Warrant, Shares outstanding

This significantly reduces the dilution to other Mkango shareholders and avoids the Company issuing 12,000,000 shares at a significant discount to the current market price of Mkango Shares.

Key Points: 
  • This significantly reduces the dilution to other Mkango shareholders and avoids the Company issuing 12,000,000 shares at a significant discount to the current market price of Mkango Shares.
  • Following the issuance of the New Shares to Talaxis pursuant to the amended warrant, Talaxis will increase its ownership of Mkango from 14,285,715 shares to 15,285,715 shares post-warrant exercise, representing an increase from 10.7% to 11.3% of the issued and outstanding shares.
  • The New Shares issued pursuant to the warrant exercise, will rank pari passu with the existing common shares.
  • Application has been made for the New Shares issued to Talaxis to be admitted to trading on AIM ("Admission").

Appia Announces Closing of Non-Brokered Private Placement

Retrieved on: 
Wednesday, December 30, 2020
Corporate finance, Adolphe Appia, Shares outstanding, Warrant, Academic disciplines

Each WC Unit is priced at $0.40 and consists of one (1) common share and one-half (0.5) of a share purchase warrant.

Key Points: 
  • Each WC Unit is priced at $0.40 and consists of one (1) common share and one-half (0.5) of a share purchase warrant.
  • Appia is a Canadian publicly-listed company in the uranium and rare earth element sectors.
  • Appia's technical team is directed by James Sykes, who has had direct and indirect involvement with over 550 million lbs.
  • Appia has 90.9 million common shares outstanding, 106.7 million shares fully diluted.

Shift Announces Completion of Exchange Offer and Plan to Exchange Remaining Outstanding Public Warrants

Retrieved on: 
Thursday, December 24, 2020
Corporate finance, Finance, Money, Financial economics, Options, Equity securities, Warrant, Fundamental analysis, Shares outstanding

The Company was advised that 6,980,262 publicly traded warrants, including 3,958 public warrants tendered through guaranteed delivery, representing approximately 92.7% of the total public warrants outstanding, were validly tendered and not withdrawn prior to the expiration of the Offer.

Key Points: 
  • The Company was advised that 6,980,262 publicly traded warrants, including 3,958 public warrants tendered through guaranteed delivery, representing approximately 92.7% of the total public warrants outstanding, were validly tendered and not withdrawn prior to the expiration of the Offer.
  • The Company expects to issue an aggregate of 1,745,078 shares of ClassA common stock (Common Stock) and pay $6,980,262 in cash in exchange.
  • The Company also executed an amendment to the warrant agreement governing its outstanding warrants and expects to exchange all remaining outstanding warrants on January 8, 2021 in exchange for an aggregate of approximately 124,253 shares of Common Stock and $497,009 in cash (the Redemption).
  • The Company expects basic and diluted weighted average shares outstanding to be approximately 76.9 million for the fourth quarter.

Michael O'Keeffe announces disposition of shares of Champion

Retrieved on: 
Wednesday, December 9, 2020
Corporate finance, Finance, Stock market, Financial economics, Fundamental analysis, Money, Shares outstanding, Security

Immediately prior to the Disposition, Mr.O'Keeffe beneficially owned, directly and through holding companies, an aggregate of 47,023,830Shares, representing 9.92% of the issued and outstanding Shares on a non-diluted basis.

Key Points: 
  • Immediately prior to the Disposition, Mr.O'Keeffe beneficially owned, directly and through holding companies, an aggregate of 47,023,830Shares, representing 9.92% of the issued and outstanding Shares on a non-diluted basis.
  • Immediately following the Disposition, Mr.O'Keeffe beneficially owns, directly and through holding companies, an aggregate of 45,023,830Shares, representing 9.50% of the issued and outstanding Shares on a non-diluted basis.
  • Mr.O'Keeffe does not own any securities which are convertible or exercisable into Shares within 60days of the date hereof.
  • As Executive Chairman of the board of directors of Champion, Mr.O'Keeffe has been and will continue to be actively involved in the business, operations and strategic planning for Champion.

IQST - iQSTEL Management Converts 21 Million Common Shares to Series B Preferred Shares Reducing Outstanding Share Count By More Than 22%

Retrieved on: 
Tuesday, December 8, 2020
Financial markets, Financial economics, Finance, Equity securities, Corporate finance, Stock market, Preferred stock, Common stock, Shares outstanding, Share

NEW YORK, Dec. 8, 2020 /PRNewswire/ -- iQSTEL, Inc. (USOTC: IQST) today announces management's conversion of 21 million common shares held among the CEO, CFO and chief commercial officer into Series B preferred shares over next days, effectively reducing the outstanding share count by more than 22%.

Key Points: 
  • NEW YORK, Dec. 8, 2020 /PRNewswire/ -- iQSTEL, Inc. (USOTC: IQST) today announces management's conversion of 21 million common shares held among the CEO, CFO and chief commercial officer into Series B preferred shares over next days, effectively reducing the outstanding share count by more than 22%.
  • These Class B preferred shares have a one-year lock-up, and upon conversion, management has opted for a one-year leak out on the shares into the outstanding share count.
  • "It is important for our current and future investors to bear witness to our conversion of these shares from common to preferred class.
  • iQSTEL Inc (OTC: IQST) ( www.iQSTEL.com ) is a US-based publicly-listed company offering leading-edge Telecommunication and Technology Services for Global Markets, with presence in 13 countries.

Kirkland Lake Gold Announces Closing of Sale of Novo Shares and Warrants

Retrieved on: 
Thursday, December 3, 2020
Kirkland Lake Gold, S&P/TSX 60 Index, Kirkland, Shares outstanding, KL, Companies, Finance, Stock market

TORONTO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Kirkland Lake Gold Ltd. (Kirkland Lake Gold or the Company) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced it has closed its previously announced sale of 18,450,000 common shares (each, a Share) of Novo Resources Corp. (Novo) and 9,225,000 warrants of Kirkland Lake Gold (each, a Warrant) to purchase Shares to qualified purchasers for gross proceeds to Kirkland Lake Gold in the amount of $45,202,500 (the Sale Transaction).

Key Points: 
  • TORONTO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Kirkland Lake Gold Ltd. (Kirkland Lake Gold or the Company) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced it has closed its previously announced sale of 18,450,000 common shares (each, a Share) of Novo Resources Corp. (Novo) and 9,225,000 warrants of Kirkland Lake Gold (each, a Warrant) to purchase Shares to qualified purchasers for gross proceeds to Kirkland Lake Gold in the amount of $45,202,500 (the Sale Transaction).
  • Prior to completion of the Sale Transaction, Kirkland Lake Gold held 27,675,168 Shares, representing approximately 12.1% of the outstanding Shares on a non-diluted basis.
  • Upon completion of the Sale Transaction, Kirkland Lake Gold owns 9,225,168 Shares, representing approximately 4% of the outstanding Shares on a non-diluted basis, representing a decrease in Kirkland Lake Golds shareholdings in Novo of approximately 7.9%.
  • This further disposition would result in an additional decrease in Kirkland Lake Golds shareholdings in Novo, following which Kirkland Lake Gold would hold 168 Shares, representing less than 1% of the outstanding Shares on a non-diluted basis.

Fairfax Announces Reset Dividend Rate on Its Series I Preferred Shares and Quarterly Dividend on Series C, D, E, F, G, H, I, J, K and M Preferred Shares and Quarterly Dividend Rate for Series D, F, H and J Preferred Shares

Retrieved on: 
Wednesday, December 2, 2020
Finance, Money, Financial markets, Corporate finance, Stock market, Equity securities, Preferred stock, Stock, Rate of return, Shares outstanding

Holders of Series I Shares have the right, at their option, exercisable not later than 5:00 p.m. (Toronto time) on December 16, 2020, to convert all or part of their Series I Shares, on a one-for-one basis, into Cumulative Floating Rate Preferred Shares, Series J (the Series J Shares) (TSX: FFH.PR.J), effective December 31, 2020.

Key Points: 
  • Holders of Series I Shares have the right, at their option, exercisable not later than 5:00 p.m. (Toronto time) on December 16, 2020, to convert all or part of their Series I Shares, on a one-for-one basis, into Cumulative Floating Rate Preferred Shares, Series J (the Series J Shares) (TSX: FFH.PR.J), effective December 31, 2020.
  • Holders of Series I Shares are not required to elect to convert all or any part of their Series I Shares into Series J Shares and holders of Series J Shares are not required to elect to convert all or any part of their Series J Shares into Series I Shares.
  • As provided in the share conditions of the Series I Shares and the Series J Shares: (i) if Fairfax determines that there would be fewer than 1,000,000 Series I Shares outstanding after December 31, 2020, all remaining Series I Shares will be automatically converted into Series J Shares on a one-for-one basis effective December 31, 2020 and Fairfax will cause the return of all Series J Shares tendered for conversion into Series I Shares; and (ii) if Fairfax determines that there would be fewer than 1,000,000 Series J Shares outstanding after December 31, 2020, all remaining Series J Shares will be automatically converted into Series I Shares on a one-for-one basis effective December 31, 2020 and Fairfax will cause the return of all Series I Shares tendered for conversion into Series J Shares.
  • The Series I Shares and the Series J Shares are listed on the Toronto Stock Exchange under the trading symbols FFH.PR.I and FFH.PR.J, respectively.